Biota Pharmaceuticals commences Phase 2 trial of laninamivir octanoate
Being conducted under the company’s contract with the US Office of Biomedical Advanced Research and Development Authority (BARDA), the multi-national, double blind trial will enroll 636 subjects and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.